These results suggest that rhil-1RA has the ability to eliminate ROS, reduce NLRP3 inflammasome generation, prevent pyroptosis, and compete with IL-1β to lower the severity of ConA-induced hepatitis. This evidence concerns the gene IL1B and hepatitis A virus infection.